-
Ask the MD: How Will Parkinson's Disease Impact my Sleep Habits? [VIDEO]
January 10, 2013
… Disorder Specialist, Maurizio Facheris, MD, responds to questions on sleep and Parkinson's disease. The "Ask the … is intended as an educational resource for the Parkinson's community, their families, and friends. Please consult with your health care provider to best address personal medical questions. We hope these …
-
Trial Participation Is Another "Tool in the Arsenal" to a Cure
July 21, 2014
… Tom McGraw and his wife, Tami. Tom McGraw started having … it wasn’t happening,” he recalled. “It made me realize, forget all this other stuff … something’s not happening here … and strong and virile, and you can do anything and accomplish anything. Nothing can stop you from taking care of …
-
Ask the MD: How Will Parkinson's Disease Affect My Sexual Health [VIDEO]
June 13, 2013
… Disorder Specialist, Maurizio Facheris, MD, responds to our communities questions on sexual health and … is intended as an educational resource for the Parkinson's community, their families, and friends. Please consult with …
-
Roche Buys MJFF-Grantee Inflazome in Deal to Develop Drugs against Inflammation
September 23, 2020
… announced this week it has been bought by pharmaceutical company Roche. The Michael J. Fox Foundation (MJFF) was an … therapies against inflammation. People with Parkinson’s show inflammation in the brain, which scientists believe may contribute to disease progression. MJFF supported Inflazome researchers …
-
Podcast: New Technologies to Treat Parkinson’s (Ask the PhD Video)
September 23, 2020
… Listen to the audio from our latest “Ask the PhD” video, where I talked with staff … some of the hardest-to-treat symptoms. Our Foundation is supporting testing of many innovative therapies harnessing …
-
Michael J. Fox Foundation Continues to Lead Search for Biomarkers of Parkinson's Disease
April 5, 2007
… NEWYORK, NY — The Michael J. Fox Foundation today announced the launch of Biomarkers 2007 , a two-year, … determine whether a treatment is reaching its hoped-for target site in the brain and exerting its desired biological … trials, or act as surrogate endpoints for clinical outcomes, would greatly improve our ability to develop and test …